Arcturus Therapeutics Holdings (ARCT) Non-Current Assets (2018 - 2026)

Arcturus Therapeutics Holdings has reported Non-Current Assets for 9 years, with the latest figure at $28.5 million in Q1 2026.

• For the quarter ending Q1 2026, Non-Current Assets fell 46.16% year-over-year to $28.5 million; the trailing twelve-month figure through Mar 2026 stood at $126.1 million (down 26.88% YoY), and the FY2025 full-year result was $29.7 million, down 22.02% from the prior year.
• Non-Current Assets for Q1 2026 stood at $28.5 million, down from $29.7 million in the prior quarter.
• The five-year high for Non-Current Assets was $64.4 million in Q3 2023, with the low at $15.0 million in Q1 2022.
• Historically, Non-Current Assets has averaged $40.9 million across 5 years, with a median of $42.8 million in 2023.
• Annual changes were most pronounced in 2022 — Non-Current Assets soared 322.36% — and 2026, when it plunged 46.16%.
• Arcturus Therapeutics Holdings' Non-Current Assets stood at $47.1 million in 2022, then decreased by 9.02% to $42.8 million in 2023, then retreated by 11.03% to $38.1 million in 2024, then dropped by 22.02% to $29.7 million in 2025, then declined by 3.95% to $28.5 million in 2026.
• The last three Non-Current Assets figures came in at $28.5 million (Q1 2026), $29.7 million (Q4 2025), and $33.1 million (Q3 2025), per Business Quant data.